About

Rolando Herrero is a leading epidemiologist whose research has fundamentally shaped our understanding of human papillomavirus (HPV) and its role in cervical cancer. His work centers on HPV genotyping, cervical cancer prevention, and the evaluation of screening technologies. Herrero’s major contributions include pioneering comparisons of PCR-based HPV detection methods, which established critical benchmarks for accurately identifying carcinogenic HPV genotypes in clinical specimens. His 2008 study comparing two genotyping methods, with 83 citations, provided essential validation for molecular screening tools used worldwide. He has also investigated the long-term stability of archived cervical cytology specimens, addressing practical challenges in large-scale epidemiological studies and biobanking. As a key investigator in the NCI/Costa Rica HPV16/18 vaccine trial, Herrero helped generate foundational evidence for HPV vaccination efficacy. His work has directly influenced global cervical cancer screening guidelines and vaccine implementation strategies. With a career spanning decades at the International Agency for Research on Cancer (IARC), Herrero’s research has had lasting impact on public health, reducing the burden of HPV-related cancers through improved detection and prevention.

Research Focus

Key Achievements

2
H-Index
2
Papers
92
Total Citations
46
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Two PCR-Based Human Papillomavirus Genotyping Methods
83 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, Guanacaste Conservation Area

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago